ID
11715
Description
This study will compare the effect of a prasugrel 10-mg maintenance dose with a clopidogrel 75-mg maintenance dose on platelet activity, approximately 1 week after the first dose of study drug, in subjects who have been taking clopidogrel 75 mg daily following a percutaneous coronary intervention (PCI) with placement of a stent, performed to treat acute coronary syndrome (ACS). https://clinicaltrials.gov/ct2/show/NCT00356135
Link
https://clinicaltrials.gov/ct2/show/NCT00356135
Keywords
Versions (1)
- 7/28/15 7/28/15 -
Uploaded on
July 28, 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility SWAP Acute Coronary Syndrome NCT00356135
Eligibility Criteria
- StudyEvent: ODM
Description
Exclusion Criteria
Description
Left main coronary artery stent
Data type
boolean
Alias
- UMLS CUI-1
- N
Description
left anterior descending (LAD) bifurcation stent
Data type
boolean
Alias
- UMLS CUI-1
- C3836455
Description
Have any form of coronary revascularization (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) planned to occur during the study (from signing consent through the final visit).
Data type
boolean
Alias
- UMLS CUI-1
- C1532338
Description
Have any form of coronary revascularization (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) planned to occur during the study (from signing consent through the final visit).
Data type
boolean
Alias
- UMLS CUI-1
- C0010055
Description
Receiving or will receive oral anticoagulation (other than aspirin and clopidogrel) that cannot be safely discontinued for the duration of the study.
Data type
boolean
Alias
- UMLS CUI-1
- C0354604
Description
Receiving or will receive other antiplatelet therapy (other than aspirin and clopidogrel) that cannot be safely discontinued for the duration of the study.
Data type
boolean
Alias
- UMLS CUI-1
- C1096021
Description
Receiving daily treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) that cannot be discontinued or are anticipated to require daily treatment with NSAIDs during the study.
Data type
boolean
Alias
- UMLS CUI-1
- C0003211
Description
history of ischemic or hemorrhagic stroke
Data type
boolean
Alias
- UMLS CUI-1
- C0559159
Description
Intracranial neoplasm
Data type
boolean
Alias
- UMLS CUI-1
- C1527390
Description
Arteriovenous malformation
Data type
boolean
Alias
- UMLS CUI-1
- C0003857
Description
Aneurysm
Data type
boolean
Alias
- UMLS CUI-1
- C0002940
Description
History of transient ischemic attack (TIA)
Data type
boolean
Alias
- UMLS CUI-1
- C0455536
Description
Have a body weight less than 60 kilograms (kg)
Data type
boolean
Similar models
Eligibility Criteria
- StudyEvent: ODM